These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24329610)

  • 1. Iron and infection in hemodialysis patients.
    Ishida JH; Johansen KL
    Semin Dial; 2014; 27(1):26-36. PubMed ID: 24329610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does iron cause bacterial infections in patients with end stage renal disease?
    Cieri E
    ANNA J; 1999 Dec; 26(6):591-6. PubMed ID: 10876474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis.
    Vaziri ND
    Am J Kidney Dis; 2013 Jun; 61(6):992-1000. PubMed ID: 23375852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iron therapy in renal failure: friend and foe?
    Afzali B; Goldsmith DJ
    J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
    Rostoker G
    Semin Dial; 2019 Jan; 32(1):22-29. PubMed ID: 29956370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous iron therapy for functional iron deficiency anemia in hemodialysis patients: a meta-analysis.
    Susantitaphong P; Alqahtani F; Jaber BL
    Am J Nephrol; 2014; 39(2):130-41. PubMed ID: 24513913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron therapy in end-stage renal disease.
    Brewster UC
    Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.
    Van Buren P; Velez RL; Vaziri ND; Zhou XJ
    Int Urol Nephrol; 2012 Apr; 44(2):499-507. PubMed ID: 21744260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron supplementation therapy in end-stage renal disease patients on maintenance hemodialysis.
    Shibata M; Taniguchi S
    Cardiovasc Hematol Disord Drug Targets; 2013 Dec; 13(3):237-42. PubMed ID: 24479720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron toxicity: relevance for dialysis patients.
    Fishbane S; Mathew A; Vaziri ND
    Nephrol Dial Transplant; 2014 Feb; 29(2):255-9. PubMed ID: 24166458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL; Johnson CA
    Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency.
    Patruta SI; Edlinger R; Sunder-Plassmann G; Hörl WH
    J Am Soc Nephrol; 1998 Apr; 9(4):655-63. PubMed ID: 9555668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice guidelines for maintaining adequate iron status with intravenous iron dextran in hemodialysis patients.
    Peacock E; Lindenfeld SM
    ANNA J; 1999 Jun; 26(3):337-43. PubMed ID: 10633605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caring for the renal failure patient: optimizing iron therapy.
    Folkert VW; Javier AM; O'Mara NB
    Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
    Easom A
    Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety Issues in Iron Treatment in CKD.
    Vaziri ND
    Semin Nephrol; 2016 Mar; 36(2):112-8. PubMed ID: 27236132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract]   [Full Text] [Related]  

  • 20. Does Helicobacter pylori infection play a role in iron deficiency anemia in hemodialysis patients?
    El-Said H; Attallah AHB; Ali-Eldin ZA
    Clin Nephrol; 2017 Oct; 88(10):177-180. PubMed ID: 28699885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.